30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Derakhshan Behrad

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Derakhshan Behrad's trades of Edgewise Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-14 2025-08-12
S Sale
18,555 +25.7%
431.89
US$1,205,302 		18,555 +25.7% 431.89 US$1,205,302
2025-05-07 2025-05-02
S Sale
41,470 +35.8%
255.05
US$3,393,593 		41,470 +35.8% 255.05 US$3,393,593
2025-02-07 2025-02-05
PlS Planned sale
85,488 +35.3%
157.57
US$1,305,239 		85,488 +35.3% 157.57 US$1,305,239
2025-02-05 2025-02-05
PrS Proposed sale
40,000
29.80
US$1,192,000 		40,000 29.80 US$1,192,000
2024-09-24 2024-09-20
S Sale
42,068 -73.6%
29.03
US$1,221,133 		42,068 -73.6% 29.03 US$1,221,133
2024-09-20 2024-09-20
PrS Proposed sale
50,000
29.50
US$1,475,000 		50,000 29.50 US$1,475,000
2024-05-03 2024-05-02
S Sale
1,718 -11.3%
18.91
US$32,487 		1,718 -11.3% 18.91 US$32,487
2024-02-09 2024-02-09
S Sale
4,800 -40.6%
20.04
US$96,209 		4,800 -40.6% 20.04 US$96,209
2024-02-09 2024-02-08
S Sale
4,600 -39.6%
20.01
US$92,049 		4,600 -39.6% 20.01 US$92,049
2024-02-09 2024-02-07
S Sale
600 -7.9%
20.00
US$12,000 		600 -7.9% 20.00 US$12,000
2024-02-07 2024-02-07
PrS Proposed sale
10,000
20.00
US$200,000 		10,000 20.00 US$200,000
2023-05-03 2023-05-02
S Sale
1,747 -19.9%
8.90
US$15,557 		1,747 -19.9% 8.90 US$15,557